NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
17 hedge funds and large institutions have $2.04M invested in NeuroMetrix, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 5 closing their positions.
0% more funds holding
Funds holding: 17 → 17 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
2.25% less ownership
Funds ownership: 9.27% → 7.02% (-2.2%)
34% less capital invested
Capital invested by funds: $3.11M → $2.04M (-$1.07M)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$87.4K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$83.6K |
| 3 |
VF
Virtu Financial
New York
|
+$83K |
| 4 |
TAM
Tucker Asset Management
Littleton,
Colorado
|
+$15.1K |
| 5 |
BlackRock
New York
|
+$8.89K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$510K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$256K |
| 3 |
Morgan Stanley
New York
|
-$60.7K |
| 4 |
Millennium Management
New York
|
-$58K |
| 5 |
SC
Stephens Consulting
Flint,
Michigan
|
-$2.21K |
NURO Hedge Fund Activity: Q1 2022 in Review
17 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q1 2022, worth a combined $2.04M — down 34% from $3.11M a quarter earlier.
Fund positioning in NURO was balanced in Q1 2022: 5 funds opened new positions, 5 closed out, 3 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $87.4K. The largest seller was Renaissance Technologies, cutting an estimated $510K.
- 17 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $2.04M of NeuroMetrix, Inc. Common Stock stock for Q1 2022, down 34% quarter-over-quarter.
- 5 funds opened new NeuroMetrix, Inc. Common Stock positions in Q1 2022 and 5 closed out, a net change of 0 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q1 2022 was Vanguard Group, an estimated $87.4K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q1 2022 was Renaissance Technologies, an estimated $510K sold.
Based on aggregated 13F filings for Q1 2022.